Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2023 | 10-2022 | 10-2021 | 10-2020 | 10-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,925 | 129 | 3,711 | 248 | 1 |
| Marketable Securities | 62 | 194 | N/A | N/A | N/A |
| Receivables | 174 | 98 | 130 | 2 | 2 |
| TOTAL | $4,190 | $436 | $3,970 | $250 | $3 |
| Non-Current Assets | |||||
| PPE Net | 1 | 49 | 17 | 135 | 133 |
| Intangibles | 86 | 131 | 160 | N/A | N/A |
| Other Non-Current Assets | 27 | 213 | 16 | 0 | 0 |
| TOTAL | $115 | $393 | $193 | $135 | $133 |
| Total Assets | $4,305 | $829 | $4,163 | $385 | $135 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 446 | 1,401 | 282 | 4 | 10 |
| Other current liabilities | 3,117 | 291 | N/A | N/A | N/A |
| TOTAL | $3,594 | $1,938 | $288 | $10 | $34 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,594 | $1,938 | $288 | $10 | $34 |
| Shareholders' Equity | |||||
| Common Shares | 12,387 | 6,726 | 6,379 | 669 | 223 |
| Retained earnings | -13,571 | -10,177 | -3,582 | -405 | -233 |
| Other shareholders' equity | 1,895 | 2,341 | 1,078 | 111 | 112 |
| TOTAL | $711 | $-1,109 | $3,875 | $375 | $102 |
| Total Liabilities And Equity | $4,305 | $829 | $4,163 | $385 | $135 |